This technology is a class of small molecule prodrugs that release carbon monoxide (CO) under specific physiological conditions with dose control and without specialized settings or external stimuli. It could be used for a wide range of medical applications such as anti-inflammation, cancer treatment, pain management, and acute kidney injury.
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Organization Type: Academic/Gov Lab
Market Keywords: pharmaceutically acceptable, dose control, easy monitoring